MAGNESIA BISURATA AROM 40CPR

MAGNESIA BISURATA COMPRESENT AROMATIC

active ingredients

Each tablet contains: Active ingredients: Magnesium Carbonate 71,0 mg, Sodium bicarbonate 64,2 mg, Calcium carbonate 525,0 mg. For the full list of excipients, see paragraph 6.1

Excellent

Sodium saccharin, Saccarosium, Corn starch, Stearate calcium, Essential mint oil.

Therapeutic indications

Syntomatic treatment of diseases of the upper digestive tract characterized by hyperacidity.

Contraindications

Hypersensitivity to active ingredients or any of the excipients listed in paragraph 6.1. Renal failure. Do not administer the Tetracyclines simultaneously (see paragraph 4.5). Do not administer other medicines within 1 or 2 hours of use of the product (see paragraph 4.5). The administration of the medicinal product in pediatric age is not recommended.

Population

One tablet to melt slowly in the mouth after meals and every time you experience pain. If necessary repeat after a quarter of an hour. DOESN'T EVERYTHING Use only for short periods of treatment. Patients with kidney failure: the reduced ability to eliminate with urine the exogenous saline supplement provided by antacids can affect potentially severe electrolytic imbalances. Treatment with magnesium salts and calcium requires periodic checks of magnesium and lime.

Conservation

This medicine does not require any special condition of conservation.

Warnings

In patients with severe renal insufficiency, plasma levels of magnesium tend to increase. In these patients, long exposures at high doses of magnesium can lead to encephalopathy or worsening of osteomalacia from dialysis. Generally, caution should be placed in case of patients with altered kidney function. In these patients, plasma levels of calcium and magnesium must be regularly monitored. In case of hypopodic diets, please note that the product contains sodium salts. Important information about some excipients Magnesia Bisurata Aromatic contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose- galactose mal absorption, or insufficiency of isomaltase saccarase, should not take this medicine.

Interactions

Please note that antacids can, with different mechanisms, interfere with oral administration of other drugs. In particular, the simultaneous administration of Tetracicline can give rise to insoluble complexes, reducing the absorption of such antibiotics. It is however appropriate not to administer other drugs within 1 or 2 hours of use of the product. Associations to avoid: - tetracycline: formation of insoluble complexes with reduction of the absorption and activity of such antibiotics. Not recommended: - chinidina: increase in plasma rates of chinidine and risk of overdose due to decrease in excretion. Associations requiring precautions of use: - indometacin, phosphorus, dexamethasone, typatics, iron salts, nitrofurantoin, lincomycin.

Effects

Based on the bibliographical data available there are no known side effects related to the specialty. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

The experience on deliberate overdose is very limited. As in all cases of overdose, the treatment must be symptomatic, adopting generic support measures.

Although there are no known adverse reactions, in pregnant women and during breastfeeding the product must be used under direct medical control.

Source: Farmadati